Monday, June 24, 2013


Maximum Drug Retail Prices (MDRP) is a government intervention to the pharmaceutical industry to set a maximum amount of drug prices in retailing, so that no other prices shall top the allowed margin of price.

Government Mediated Access Prices (GMAP), also known as ADVISORY COUNCIL PRICE REGULATION RESOLUTION 2009-001, is a mediated action made by the government to convince drug companies to lower the prices of the their products that can be acceptable in the budget of the consumers. Almost all drugs inclusive in this were slashed into half of the original prices.